Work

A Decision Analysis to Define the Thresholds at Which the Risks of Combination Infliximab and Azathioprine Therapy Outweigh Its Benefits

Year: 2009

Type: article

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-200910003-01257

Authors: Corey Siegel, Samuel Finlayson, Bruce Sands, Anna Tosteson

Institutions: Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth–Hitchcock Medical Center, Massachusetts General Hospital

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2978558286

FWCI:

Cites:

Cited by:

Related to: 10